Litchev Boyan Vesselinov (CIK 0001902726)

Latest company ownership

Role: Chief Medical Officer
Shares held
1,150
Last filed at
Dec 19, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 31, 2022 Dec 19, 2022 Indaptus Therapeutics, Inc. Chief Medical Officer Buy 90.0 +1,150 100.00% $2.5K